Hansard Adam

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
5
Insider Sells Sum
$348,755.09

Insider Activity of Hansard Adam

According to the SEC Form 4 filings, Hansard Adam, being in a position of

  1. Chief Commercial Officer at Applied Therapeutics, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 48871 share for $263,415,
    over all time since 2021-05-26, has bought 0 shares, and sold 66945 shares for $348,755.

The largest sale of all time was on 2024-03-14 and amounted to 48871 share of Applied Therapeutics, Inc. for $263,415.

Biography of Hansard Adam

No biography is available at this moment.

2024-03-14SaleApplied Therapeutics, Inc.
APLT
Chief Commercial Officer
48,871
0.0407%
$5.39$263,415-4.63%
2023-11-30SaleApplied Therapeutics, Inc.
APLT
Chief Commercial Officer
965
0.0012%
$1.97$1,901+147.6%
2023-09-27SaleApplied Therapeutics, Inc.
APLT
Chief Commercial Officer
9,720
0.0157%
$2.70$26,244+66.1%
2023-01-11SaleApplied Therapeutics, Inc.
APLT
Chief Commercial Officer
4,495
0.0074%
$0.91$4,090+48.58%
2021-05-26SaleApplied Therapeutics, Inc.
APLT
Chief Commercial Officer
2,894
0.0101%
$18.35$53,105-44.75%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.